These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

771 related articles for article (PubMed ID: 24519981)

  • 1. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
    Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
    Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
    Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
    Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance.
    Smith LM; Kostylev MA; Lee S; Strittmatter SM
    J Biol Chem; 2019 Apr; 294(15):6042-6053. PubMed ID: 30787106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.
    Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM
    Nat Neurosci; 2012 Sep; 15(9):1227-35. PubMed ID: 22820466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues.
    Chen S; Yadav SP; Surewicz WK
    J Biol Chem; 2010 Aug; 285(34):26377-83. PubMed ID: 20576610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models.
    Kostylev MA; Kaufman AC; Nygaard HB; Patel P; Haas LT; Gunther EC; Vortmeyer A; Strittmatter SM
    J Biol Chem; 2015 Jul; 290(28):17415-38. PubMed ID: 26018073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein.
    Aimi T; Suzuki K; Hoshino T; Mizushima T
    J Neurochem; 2015 Aug; 134(4):611-7. PubMed ID: 25963375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation.
    Bove-Fenderson E; Urano R; Straub JE; Harris DA
    J Biol Chem; 2017 Oct; 292(41):16858-16871. PubMed ID: 28842494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-amyloid oligomers and cellular prion protein in Alzheimer's disease.
    Gunther EC; Strittmatter SM
    J Mol Med (Berl); 2010 Apr; 88(4):331-8. PubMed ID: 19960174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular prion protein as a therapeutic target in Alzheimer's disease.
    Laurén J
    J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Alkaline Phosphatase-Fused Mouse Prion Protein and Its Application in Toxic Aβ Oligomer Detection.
    Tsukakoshi K; Kubo R; Ikebukuro K
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5).
    Haas LT; Kostylev MA; Strittmatter SM
    J Biol Chem; 2014 Oct; 289(41):28460-77. PubMed ID: 25148681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
    Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
    J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases.
    Iraci N; Stincardini C; Barreca ML; Biasini E
    Virus Res; 2015 Sep; 207():62-8. PubMed ID: 25456402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a
    Younan ND; Chen KF; Rose RS; Crowther DC; Viles JH
    J Biol Chem; 2018 Aug; 293(34):13090-13099. PubMed ID: 29887525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aβ induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates.
    Béland M; Bédard M; Tremblay G; Lavigne P; Roucou X
    Neurobiol Aging; 2014 Jul; 35(7):1537-48. PubMed ID: 24602510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Prion Peptide 107-120 Protects Neuroblastoma SH-SY5Y Cells against Oligomers Associated with Alzheimer's Disease.
    Rezvani Boroujeni E; Hosseini SM; Fani G; Cecchi C; Chiti F
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Aβ aggregates can inhibit prion propagation.
    Sarell CJ; Quarterman E; Yip DC; Terry C; Nicoll AJ; Wadsworth JDF; Farrow MA; Walsh DM; Collinge J
    Open Biol; 2017 Nov; 7(11):. PubMed ID: 29142106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.